Microalbuminuria: a marker of systemic disease
Gosling, P.
British Journal of Hospital Medicine 54(6): 285-290
1995
ISSN/ISBN: 0007-1064 PMID: 8542177 Document Number: 440769
Document emailed within 1 workday
Related Documents
Ghai, R.; Verma, N.P.; Goel, A.; Bhatnagar, M.K.; Kapoor, P.; Vashishta, A. 1994: Microalbuminuria in non insulin dependent diabetes and essential hypertension: a marker of severe disease Journal of the Association of Physicians of India 42(10): 771-774Ahmed, S. 1995: Microalbuminuria in non-insulin dependent diabetes and essential hypertension--a marker of severe disease Journal of the Association of Physicians of India 43(7): 517-518
Turan, B.; Gallati, H.; Erdi, H.; Gürler, A.; Michel, B.A.; Villiger, P.M. 1997: Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity Journal of Rheumatology 24(1): 128-132
Waghmare, P.; Goswami, K. 2016: Microalbuminuria: a Mere Marker or An Ominous Sign? Journal of the Association of Physicians of India 64(3): 61-65
Taute, B-M.; Taute, R.; Heins, S.; Behrmann, C.; Podhaisky, H. 2004: Hyperhomocysteinemia: marker of systemic atherosclerosis in peripheral arterial disease International Angiology: a Journal of the International Union of Angiology 23(1): 35-40
Bar, J.; Friedman, S.; Erman, A.; Kaplan, B.; Hod, M.; Boner, G.; Ovadia, J. 1996: Microalbuminuria as an early marker of severity in hypertensive pregnant women Journal of Human Hypertension 10(Suppl 3): S111-S114
Pontremoli, R.; Viazzi, F.; Sofia, A.; Tomolillo, C.; Ruello, N.; Bezante, G.P.; Del Sette, M.; Martinoli, C.; Lotti, R.; Sacchi, G.; Deferrari, G. 1997: Microalbuminuria: a marker of cardiovascular risk and organ damage in essential hypertension Kidney International. Suppl 63: S163-S165
Nand, N.; Jain, R.; Seth, S.; Sen, J.; Sharma, M. 2010: A new marker of carotid atherosclerosis in middle aged adults: cystatin C or microalbuminuria Indian Heart Journal 62(4): 320-323
Caligaris-Cappio, F.; Bertero, M.T.; Converso, M.; Stacchini, A.; Vinante, F.; Romagnani, S.; Pizzolo, G. 1995: Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity Clinical and Experimental Rheumatology 13(3): 339-343
Gomes, M.B.; Lucchetti, M.R.; Gazzola, H.; Dimetz, T.; Lobão, V.I.; Stum, J.A. 1997: Lipids, microalbuminuria and systemic blood pressure in patients with insulin-dependent diabetes mellitus Arquivos Brasileiros de Cardiologia 68(2): 85-89
Marre, M.; Garcia Puig, J.; Kokot, F.; Fernandez, M.; Jermendy, G.; Opie, L.; Moyseev, V.; Scheen, A.; Ionescu-Tirgoviste, C.; Saldanha, M.H.; Halabe, A.; Williams, B.; Mion, D.; Ruiz, M.; Hermansen, K.; Tuomilehto, J.; Finizola, B.; Pozza, G.; Chastang, C.; Ollivier, J.P.; Amouyel, P.; Asmar, R. 2003: Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 21(1): S19-S24
Jensen, J.S.; Feldt-Rasmussen, B.F.; Strandgaard, S.; Schroll, M.; Borch-Johnsen, K. 2002: Microalbuminuria is associated with a fourfold increased risk of ischemic heart disease among hypertensive patients Ugeskrift for Laeger 164(32): 3773-3777
Scagliusi, P.; Cafiero, S.; Silvestris, F.; Frassanito, A.; Pipitone, V. 1987: Anticardiolipin antibodies: a new sero-immunologic marker in systemic lupus erythematosus? Recenti Progressi in Medicina 78(5): 230-234
Casoinic, F.; Sâmpelean, D.; Bădău, C.ăt.ăl.; Prună, L. 2009: Nonalcoholic fatty liver disease--a risk factor for microalbuminuria in type 2 diabetic patients Romanian Journal of Internal Medicine 47(1): 55-59
Yamane, K.; Ihn, H.; Kubo, M.; Yazawa, N.; Kikuchi, K.; Soma, Y.; Tamaki, K. 2000: Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis Journal of Rheumatology 27(4): 930-934
Hryckiewicz, K.; Juszczyk, J.; Samet, A.; Arłukowicz, E.; Sledzińska, A.; Bolewska, B. 2006: Procalcitonin as a diagnostic marker in systemic inflammatory response syndrome (SIRS) and sepsis Przeglad Epidemiologiczny 60(1): 7-15
Jothy, S.; Sawka, R.J. 1981: Presence of monocytes in systemic lupus erythematosus-associated glomerulonephritis: marker study and significance Archives of Pathology and Laboratory Medicine 105(11): 590-593
Morelli, S.; Ferri, C. 1996: Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction? Journal of Rheumatology 23(4): 789-791
Malcić, I.; Buljević, A.D.; Vucinić, D.; Carin, R. 1996: Polyarteritis nodosa--cutaneous or systemic form? Possible role of bacterial superantigens in the onset of systemic disease Reumatizam 43(1): 16-24
Goch, J.H.; Sadurska, J. 2002: C-reactive protein in coronary disease--pathogenic factor or marker of the disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(73): 70-73